Fulgent Genetics, Inc. Q2 FY2025 Earnings Call

Fulgent Genetics, Inc. (FLGT)

Earnings Call FY2025 Q2 Call date: 2025-08-01 Concluded

Quarter scorecard

Revenue

$81.80M

+15.2% YoY

Gross margin

42.1%

+4.8 pp YoY

Net income

-$18.96M

Laboratory Services $81.80M

+15.2%

Therapeutic Development $0

Buybacks (derived)

$2.21M

Shares repurchased

200,000